Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis

The efficacy of immune checkpoint inhibitors (ICIs) on KRAS-mutant advanced non-small cell lung cancer (NSCLC) remains controversial. This retrospective study compared the effects of ICIs treatment and chemotherapy on the prognosis of patients with KRAS-mutant advanced NSCLC and different mutant sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Xiaodong, Si, Jinfei, Guan, Yelan, Xu, Yibing, Shao, Lan, Zhang, Yiping, Xu, Chunwei, Pan, Weiwei, Lu, Yuanzhi, Song, Zhengbo, Wang, Wenxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007168/
https://www.ncbi.nlm.nih.gov/pubmed/36915627
http://dx.doi.org/10.1515/med-2023-0653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007168/
https://www.ncbi.nlm.nih.gov/pubmed/36915627
http://dx.doi.org/10.1515/med-2023-0653

Ejemplares similares